Skip to main content

$0.825 -0.005 (-0.60%)

High

$0.85

Low

$0.83

Trades

5

Turnover

$44,818

Volume

53,508
30 June 2023 at 3:52pm
Register to track CD1 and receive email alerts.
Subject
CD1 Ann: Appendix 3Z - Final Director's Interest Notice

CD1 Ann: Appendix 3Z - Final Director's Interest Notice

CD1 Ann: Appendix 3Z - Final Director's Interest Notice

CD1 Ann: Appendix 3X - Initial Director's Interest Notice

CD1 Ann: Appendix 3X - Initial Director's Interest Notice

CD1 Ann: Appendix 3X - Initial Director's Interest Notice

CD1 Ann: Responsible Entity Appointment

CD1 Ann: KAM: Responsible Entity appointment

CD1 Ann: Results of General Meeting

CD1 Ann: Chairs Address and General Meeting Presentation

CD1 Ann: Net Tangible Asset Backing & Fund Update

CD1 Ann: CD Private Equity Funds 1, 2, 3 & 4 Unitholder Update

CD1 Ann: Appendix 4G

CD1 Ann: Appendix 4E and Full Year Statutory Accounts

CD1 Ann: Evans & Partners Funds Unitholder Update

CD1 Ann: KAM: Proposed Responsible Entity appointment

CD1 Ann: Explanatory Memorandum and Notice of Meeting

CD1 Ann: Proposal seeking change of RE

CD1 Ann: Net Tangible Asset Backing & Fund Update

CD1 Ann: Quarterly investment update - March 2023

CD1 Ann: Net Tangible Asset Backing & Fund Update

CD1 Ann: Process commenced seeking change of RE

CD1 Ann: Net Tangible Asset Backing & Fund Update

CD1 Ann: Silicon Valley Bank update

CD1 Ann: Fund Payment Notice

CD1 Ann: Response to Media Speculation

CD1 Ann: PE1:Response to Media Speculation

CD1 Ann: Net Tangible Asset Backing & Fund Update

CD1 Ann: Quarterly investment update - December 2022

CD1 Ann: CD Private Equity Fund Series Update - February 2023

CD1 Ann: Distribution announcement

CD1 Ann: Dividend/Distribution - CD1

CD1 Ann: Net Tangible Asset Backing & Fund Update

CD1 Ann: Net Tangible Asset Backing & Fund Update

CD1 Ann: Half-yearly report and accounts - 30 September 2022

CD1 Ann: Fund Payment Notice

CD1 Ann: Quarterly investment update - September 2022

CD1 Ann: Net Tangible Asset Backing & Fund Update

CD1 Ann: Results of General Meeting

CD1 Ann: General Meeting Presentation 7 November 2022

CD1 Ann: Change of Registry Address

CD1 Ann: Dividend/Distribution - CD1

CD1 Ann: Withdrawal of Merger Proposal & Announcement of Distribution

CD1 Ann: Supplementary Explanatory Memorandum

CD1 Ann: Supplementary Product Disclosure Statement

CD1 Ann: Merger Proposal Update

CD1 Ann: Merger Proposal Update

CD1 Ann: Net Tangible Asset Backing & Fund Update

CD1 Ann: Notice of Meeting

CD1 Ann: Product Disclosure Statement

Register to track CD1 and receive email alerts.